Computational Biology Market, By Type, By Tools, By Geography

Description

Computational Biology Market is estimated to be valued at USD 10.76 Bn in 2026 and is expected to reach USD 33.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 10.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.80%	2033 Value Projection:	USD 33.86 Bn

Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received USD 55 Mn in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market.

Market Segmentation

Global Computational Biology Market, By Type (Revenue, USD Bn, 2021 - 2033)
Cellular and Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
- Drug Discovery
- Drug Development
Global Computational Biology Market, By Tools (Revenue, USD Bn, 2021 - 2033)
Content/Database
Analysis Software and Services
IT Infrastructure (Hardware)
Global Computational Biology Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
Accelrys
Certara, L.P.
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc. (Rosa & Co. LLC)
Genedata AG
Insilico Biotechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.

Product Code: CMI3915

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Tools
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Computational Biology Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cellular and Biological Simulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Computational Genomics
  - Computational Proteomics
  - Pharmacogenomics
  - Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Drug Discovery
  - Drug Development

5. Global Computational Biology Market, By Tools, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Content/Database
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Analysis Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
IT Infrastructure (Hardware)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Computational Biology Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Accelrys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chemical Computing Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Compugen, ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Entelos, Inc. (Rosa and Co. LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Insilico Biotechnology AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leadscope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nimbus Discovery LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Rhenovia Pharma SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Simulation Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

8. Section

Research Methodology
About Us